1. Home
  2. SINT vs SNGX Comparison

SINT vs SNGX Comparison

Compare SINT & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SINT
  • SNGX
  • Stock Information
  • Founded
  • SINT 1996
  • SNGX 1987
  • Country
  • SINT United States
  • SNGX United States
  • Employees
  • SINT N/A
  • SNGX N/A
  • Industry
  • SINT Medical/Dental Instruments
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SINT Health Care
  • SNGX Health Care
  • Exchange
  • SINT Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • SINT 7.9M
  • SNGX 6.5M
  • IPO Year
  • SINT 2014
  • SNGX 1987
  • Fundamental
  • Price
  • SINT $2.84
  • SNGX $1.93
  • Analyst Decision
  • SINT Strong Buy
  • SNGX
  • Analyst Count
  • SINT 1
  • SNGX 0
  • Target Price
  • SINT $28.00
  • SNGX N/A
  • AVG Volume (30 Days)
  • SINT 334.3K
  • SNGX 18.1K
  • Earning Date
  • SINT 05-15-2025
  • SNGX 05-09-2025
  • Dividend Yield
  • SINT N/A
  • SNGX N/A
  • EPS Growth
  • SINT N/A
  • SNGX N/A
  • EPS
  • SINT N/A
  • SNGX N/A
  • Revenue
  • SINT $2,569,000.00
  • SNGX $2,342.00
  • Revenue This Year
  • SINT $3.26
  • SNGX N/A
  • Revenue Next Year
  • SINT $21.87
  • SNGX N/A
  • P/E Ratio
  • SINT N/A
  • SNGX N/A
  • Revenue Growth
  • SINT N/A
  • SNGX N/A
  • 52 Week Low
  • SINT $1.71
  • SNGX $1.68
  • 52 Week High
  • SINT $8.60
  • SNGX $14.83
  • Technical
  • Relative Strength Index (RSI)
  • SINT 52.40
  • SNGX 49.95
  • Support Level
  • SINT $2.66
  • SNGX $1.86
  • Resistance Level
  • SINT $2.92
  • SNGX $1.97
  • Average True Range (ATR)
  • SINT 0.22
  • SNGX 0.09
  • MACD
  • SINT -0.02
  • SNGX 0.01
  • Stochastic Oscillator
  • SINT 43.02
  • SNGX 70.59

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: